Regarding hepatic encephalopathy which of the following is TRUE / FALSE? 1. The correlation between severity of liver disease and height of ammonia levels is often poor 2. Lactulose, results in colonic alkalification 3. The mainstay of treatment for encephalopathy is lactulose, an absorbable disaccharide. 4. Rifaximin at 550 mg twice daily is not very effective in treating encephalopathy 5. It is a poor prognostic sign
**Question:** Regarding hepatic encephalopathy which of the following is TRUE / FALSE? 1. The correlation between severity of liver disease and height of ammonia levels is often poor 2. Lactulose, results in colonic alkalification 3. The mainstay of treatment for encephalopathy is lactulose, an absorbable disaccharide. 4. Rifaximin at 550 mg twice daily is not very effective in treating encephalopathy 5. It is a poor prognostic sign
**Core Concept:** Hepatic encephalopathy is a neuropsychiatric disorder that occurs due to the accumulation of neurotoxins like ammonia in the brain as a result of liver failure or dysfunction. Treatment options include pharmacotherapy and lifestyle modifications.
**Why the Correct Answer is Right:**
1. The correlation between the severity of liver disease and ammonia levels is often poor:
- Hepatic encephalopathy is a complex clinical syndrome that involves multiple factors, not solely ammonia levels.
- Although ammonia is a key neurotoxin involved in hepatic encephalopathy, the correlation between liver disease severity and ammonia levels is not always straightforward.
2. Lactulose, results in colonic alkalization:
- Lactulose is a non-absorbable disaccharide that promotes colonic fermentation, leading to colonic alkalization.
- This action helps to reduce ammonia absorption from the gut and decrease ammonia levels in the blood, thus improving cerebral ammonia clearance.
3. The mainstay of treatment for hepatic encephalopathy is lactulose:
- Lactulose is a non-absorbable disaccharide that promotes colonic fermentation and reduces ammonia absorption from the gut.
- By decreasing blood ammonia levels, it improves cerebral ammonia clearance and helps to manage hepatic encephalopathy.
4. Rifaximin at 550 mg twice daily is not very effective in treating hepatic encephalopathy:
- Rifaximin is a broad-spectrum antibiotic that primarily addresses bacterial overgrowth in the gut.
- While rifaximin may help reduce bacterial overgrowth, its specific mechanism does not directly address the ammonia reduction in the blood.
- A non-absorbable disaccharide like lactulose is more effective in reducing ammonia levels and improving cerebral ammonia clearance.
5. It is a poor prognostic sign:
- Hepatic encephalopathy can be a manifestation of advanced liver disease, indicating poor prognosis.
- The severity of hepatic encephalopathy can hint at the extent of liver damage and its consequences on neurotoxin absorption.
**Why Each Wrong Answer is Incorrect:**
1. False: Liver disease severity determines ammonia levels, not the other way around.
2. False: Rifaximin is a more effective treatment than lactulose in hepatic encephalopathy management.
3. False: Liver function does not determine the efficacy of lactulose treatment; lactulose reduces ammonia levels directly.
4. False: Liver function does not determine the efficacy of rifaximin treatment; rifaximin